These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 30322678)

  • 1. Osteogenesis imperfecta type VIII: Association with increased nuchal translucency and prenatal diagnosis by targeted exome sequencing.
    Zhen L; Jiang F; Li DZ
    Eur J Obstet Gynecol Reprod Biol; 2019 Apr; 235():128-129. PubMed ID: 30322678
    [No Abstract]   [Full Text] [Related]  

  • 2. A novel P3H1 mutation is associated with osteogenesis imperfecta type VIII and dental anomalies.
    Kantaputra PN; Dejkhamron P; Intachai W; Ngamphiw C; Ketudat Cairns JR; Kawasaki K; Ohazama A; Olsen B; Tongsima S; Angkurawaranon S
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2021 Dec; 132(6):e198-e207. PubMed ID: 33737016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteogenesis imperfecta caused by COL1A1, CRTAP and LEPRE1 mutations. Report of 2cases.
    Caudevilla Lafuente P; Izquierdo-Álvarez S; Labarta Aizpún JI
    Med Clin (Barc); 2019 Oct; 153(8):336-337. PubMed ID: 30389107
    [No Abstract]   [Full Text] [Related]  

  • 4. A new case of osteogenesis imperfecta type VIII and retinal detachment.
    de Souza LT; Nunes RR; de Azevedo Magalhães O; Maria Félix T
    Am J Med Genet A; 2021 Jan; 185(1):238-241. PubMed ID: 33098264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteogenesis imperfecta type II: prenatal diagnosis and association with increased nuchal translucency and hypoechogenicity of the cranium.
    Chen CP; Su YN; Chang TY; Huang MC; Pan CH; Chern SR; Su JW; Wang W
    Taiwan J Obstet Gynecol; 2012 Jun; 51(2):315-8. PubMed ID: 22795121
    [No Abstract]   [Full Text] [Related]  

  • 6. [Increased nuchal translucency in osteogenesis imperfecta].
    Schönewolf-Greulich B; Skibsted L; Maroun LL; Lund AM; Brøndum-Nielsen K
    Ugeskr Laeger; 2011 Mar; 173(13):973-4. PubMed ID: 21453639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteogenesis imperfecta due to compound heterozygosity for the LEPRE1 gene.
    Moul A; Alladin A; Navarrete C; Abdenour G; Rodriguez MM
    Fetal Pediatr Pathol; 2013 Oct; 32(5):319-25. PubMed ID: 23301918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe cases of osteogenesis imperfecta type VIII due to a homozygous mutation in P3H1 (LEPRE1) and review of the literature.
    Bala MM; Bala KA
    Adv Clin Exp Med; 2021 Dec; 30(12):1233-1238. PubMed ID: 34637196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prenatal diagnosis of type II osteogenesis imperfecta, describing a new mutation in the COL1A1 gene.
    Aerts M; Van Holsbeke C; de Ravel T; Devlieger R
    Prenat Diagn; 2006 Apr; 26(4):394. PubMed ID: 16566045
    [No Abstract]   [Full Text] [Related]  

  • 10. Prolyl 3-hydroxylase 1 deficiency causes a recessive metabolic bone disorder resembling lethal/severe osteogenesis imperfecta.
    Cabral WA; Chang W; Barnes AM; Weis M; Scott MA; Leikin S; Makareeva E; Kuznetsova NV; Rosenbaum KN; Tifft CJ; Bulas DI; Kozma C; Smith PA; Eyre DR; Marini JC
    Nat Genet; 2007 Mar; 39(3):359-65. PubMed ID: 17277775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteogenesis Imperfecta: Search for Mutations in Patients from the Republic of Bashkortostan (Russia).
    Nadyrshina D; Zaripova A; Tyurin A; Minniakhmetov I; Zakharova E; Khusainova R
    Genes (Basel); 2022 Jan; 13(1):. PubMed ID: 35052464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Antenatal Evaluations with Postmortem and Genetic Findings in the Series of Fetal Osteogenesis Imperfecta.
    Senturk L; Gulec C; Sarac Sivrikoz T; Kayserili H; Kalelioglu IH; Avci S; Has R; Coucke P; Kalayci T; Wollnik B; Karaman B; Toksoy G; Symoens S; Yigit G; Yuksel A; Basaran S; Tuysuz B; Altunoglu U; Uyguner ZO
    Fetal Diagn Ther; 2024; 51(3):285-299. PubMed ID: 38346409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and molecular analysis in families with autosomal recessive osteogenesis imperfecta identifies mutations in five genes and suggests genotype-phenotype correlations.
    Caparrós-Martin JA; Valencia M; Pulido V; Martínez-Glez V; Rueda-Arenas I; Amr K; Farra C; Lapunzina P; Ruiz-Perez VL; Temtamy S; Aglan M
    Am J Med Genet A; 2013 Jun; 161A(6):1354-69. PubMed ID: 23613367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteogenesis imperfecta and other skeletal dysplasias presenting with increased nuchal translucency in the first trimester.
    Makrydimas G; Souka A; Skentou H; Lolis D; Nicolaides K
    Am J Med Genet; 2001 Jan; 98(2):117-20. PubMed ID: 11223845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrence of perinatal lethal osteogenesis imperfecta in sibships: parsing the risk between parental mosaicism for dominant mutations and autosomal recessive inheritance.
    Pyott SM; Pepin MG; Schwarze U; Yang K; Smith G; Byers PH
    Genet Med; 2011 Feb; 13(2):125-30. PubMed ID: 21239989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fetus with osteogenesis imperfecta presenting as increased nuchal translucency thickness in the first trimester.
    Hsieh CT; Yeh GP; Wu HH; Wu JL; Chou PH; Lin YM
    J Clin Ultrasound; 2008 Feb; 36(2):119-22. PubMed ID: 17764073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel mutation in LEPRE1 that eliminates only the KDEL ER- retrieval sequence causes non-lethal osteogenesis imperfecta.
    Takagi M; Ishii T; Barnes AM; Weis M; Amano N; Tanaka M; Fukuzawa R; Nishimura G; Eyre DR; Marini JC; Hasegawa T
    PLoS One; 2012; 7(5):e36809. PubMed ID: 22615817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased nuchal translucency in the first trimester as a sign of osteogenesis imperfecta.
    Viora E; Sciarrone A; Bastonero S; Errante G; Campogrande M; Botta G; Franceschini P
    Am J Med Genet; 2002 May; 109(4):336-7. PubMed ID: 11992492
    [No Abstract]   [Full Text] [Related]  

  • 19. A founder mutation in LEPRE1 carried by 1.5% of West Africans and 0.4% of African Americans causes lethal recessive osteogenesis imperfecta.
    Cabral WA; Barnes AM; Adeyemo A; Cushing K; Chitayat D; Porter FD; Panny SR; Gulamali-Majid F; Tishkoff SA; Rebbeck TR; Gueye SM; Bailey-Wilson JE; Brody LC; Rotimi CN; Marini JC
    Genet Med; 2012 May; 14(5):543-51. PubMed ID: 22281939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteogenesis imperfecta associated with increased nuchal translucency as a first ultrasound sign: report of another case.
    Viora E; Sciarrone A; Bastonero S; Errante G; Botta G; Franceschini PG; Campogrande M
    Ultrasound Obstet Gynecol; 2003 Feb; 21(2):200-2. PubMed ID: 12601849
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.